Animal Test
Preclinical Animal Safety Testing
According to the FDA, EMA, and other regulatory guidance for pharmaceutical industry, GLP preclinical animal testing is required to address the safety issues for anticipated exposure of products in human subjects.
Pharmacology Studies - Efficacy
- In Vivo Models (Rodent Species: Rat, Mouse, Guinea pig, Hamster)
- Routes of Administration
- Intra-venous, Intra-arterial, Intra-cranial, Intra-tracheal, Subcutaneous, Customize, Intraperitoneal, Intra-articular, Intranasal, Intracerebral, Oral, Intramuscular
- Dosing :Single, Repeated injection by 1-3 doses , Acute, Subchronic, Chronic studies (14/28/90 days in general)
- Disease Model
- • Respiratory (*Chronic obstructive pulmonary disease (COPD) *Rhinitis *Asthma )
- • Acute liver failure (ALF)
- • Inflammatory bowel disease (IBD)
- • Acute/ Chronic kidney diseases (AKD/CKD)
- • Diabetes
- • Skin care (*Whitening ability *Humidity retention *Hair restoration)
- • Cardiovascular
- • Solid tumor
- • Customized model